Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Saved in:
Bibliographic Details
Title: Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.
Authors: Joshi SS; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Catenacci DVT; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Peterson JD; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Zalupski MM; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Sehdev A; Division of Hematology/Oncology, Indiana University, Indianapolis, Indiana., Wade J; Decatur Memorial Hospital, Decatur, Illinois., Sadiq A; Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana., Picozzi VJ; Section of Hematology and Oncology, Virginia Mason Medical Center, Seattle, Washington., Amico A; The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois., Marsh R; Northshore University Health System, Evanston, Illinois., Kozloff MF; UChicago Medicine Ingalls Memorial, Harvey, Illinois., Polite BN; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Kindler HL; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Sharma MR; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. manish.sharma@startmidwest.com.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 18-24. Date of Electronic Publication: 2019 Sep 26.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-19-1483